RD
Robert J Deluccia
Director

Robert J Deluccia insider trades: Acurx Pharmaceuticals (ACXP) stock purchases

Director, Acurx Pharmaceuticals Last trade Jan 6, 2025 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2006
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 6, 2025ACXP↑ Buy$50K
Jul 27, 2022ACXP↑ Buy$75K
Nov 19, 2021ACXP↑ Buy$25K
Mar 18, 2014DPRX↑ Buy$25K
Dec 31, 2007MACM.OB↑ Buy$3K
Oct 10, 2007MACM↑ Buy$25K
Nov 2, 2006MACM.OB↑ Buy$1K
Oct 16, 2006MACM.OB↑ Buy$1K
Oct 11, 2006MACM.OB↑ Buy$3K
Oct 5, 2006MACM.OB↑ Buy$1K
Oct 4, 2006MACM.OB↑ Buy$1K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert J Deluccia's insider trades

Robert J Deluccia is a director at Acurx Pharmaceuticals (ACXP). Since Oct 4, 2006, Robert has reported 11 open-market purchases worth $210K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), other transactions (2 filings), option exercises (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.